These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 8752564)

  • 1. [The efficacy of excluding anti-HVC-positive donors by ELISA 2 in the prevention of posttransfusion hepatitis].
    Barrera JM; Bruguera M; González M; Gálvez A; Castillo R; Rodés J
    Gastroenterol Hepatol; 1996 May; 19(5):240-2. PubMed ID: 8752564
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prospective assessment of donor blood screening for antibody to hepatitis C virus by first- and second-generation assays as a means of preventing posttransfusion hepatitis.
    Takano S; Nakamura K; Kawai S; Yokosuka O; Satomura Y; Omata M
    Hepatology; 1996 Apr; 23(4):708-12. PubMed ID: 8666321
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Prospective study of the incidence of post-transfusion hepatitis after the exclusion of donors positive for anti-HCV ELISA 2].
    Salmerón FJ; Gila A; Oyonarte S; Palacios A; Pérez Ruiz M; Fernández Montoya A; Ruiz Extremera A
    Med Clin (Barc); 1995 Nov; 105(17):641-4. PubMed ID: 8558961
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Post-transfusion hepatitis in Navarra. Evidence of acute hepatitis C virus infection without elevation of aminotransferases].
    Huarte Muniesa MP; Maluenda Colomer MD; Civeira Murillo MP; Medarde Agustín A; Prieto Valtueña JM
    Med Clin (Barc); 1994 Nov; 103(16):601-5. PubMed ID: 7996915
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of screening blood donors for hepatitis C antibody on posttransfusion hepatitis: a prospective study with a second-generation anti-hepatitis C virus assay.
    Huang YY; Yang SS; Wu CH; Shih WS; Huang CS; Chen PH; Lin YM; Shen CT; Chen DS
    Transfusion; 1994 Aug; 34(8):661-5. PubMed ID: 7521077
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Performance of three generations of anti-hepatitis C virus enzyme-linked immunosorbent assays in donors and patients.
    Vrielink H; Reesink HW; van den Burg PJ; Zaaijer HL; Cuypers HT; Lelie PN; van der Poel CL
    Transfusion; 1997 Aug; 37(8):845-9. PubMed ID: 9280331
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Frequency and characteristics of post-transfusion hepatitis in Greece with emphasis on hepatitis C: comparing second- and third-generation assays.
    Makris K; Kouvelis V; Drakopoulos I; Oikonomou E; Maniatis A
    Transfus Med; 1995 Sep; 5(3):213-24. PubMed ID: 8593527
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Markers for transfusion-associated hepatitis in north Indian blood donors: prevalence and trends.
    Singh B; Verma M; Verma K
    Jpn J Infect Dis; 2004 Apr; 57(2):49-51. PubMed ID: 15118208
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatitis C virus infection in post-transfusion hepatitis. An analysis with first- and second-generation assays.
    Aach RD; Stevens CE; Hollinger FB; Mosley JW; Peterson DA; Taylor PE; Johnson RG; Barbosa LH; Nemo GJ
    N Engl J Med; 1991 Nov; 325(19):1325-9. PubMed ID: 1656258
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence & significance of hepatitis C virus (HCV) seropositivity in blood donors.
    Thakral B; Marwaha N; Chawla YK; Saluja K; Sharma A; Sharma RR; Minz RW; Agnihotri SK
    Indian J Med Res; 2006 Oct; 124(4):431-8. PubMed ID: 17159264
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevention of posttransfusion hepatitis B and C by screening for antibody to hepatitis C virus and antibody to HBcAg.
    Chung HT; Lee JS; Lok AS
    Hepatology; 1993 Nov; 18(5):1045-9. PubMed ID: 7693569
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The recent incidence of post-transfusion hepatitis C since the implementation of the anti-HCV screening program for blood donors].
    Katayama T
    Nihon Rinsho; 1995 Sep; 53 Suppl(Pt 1):383-8. PubMed ID: 7563764
    [No Abstract]   [Full Text] [Related]  

  • 13. Evaluation of antibodies to hepatitis C virus in a study of transfusion-associated hepatitis.
    Esteban JI; González A; Hernández JM; Viladomiu L; Sánchez C; López-Talavera JC; Lucea D; Martin-Vega C; Vidal X; Esteban R
    N Engl J Med; 1990 Oct; 323(16):1107-12. PubMed ID: 2170839
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Epidemiological information obtained from anti-hepatitis C virus screening in blood donors and candidates for autologous transfusion from 1992 to 1996 in the Alpes-Maritimes region].
    Ouzan D; Pesle B; Baldini E; Rimbourg H; Darphin F; Cohen N; Brichetti A; Follana R
    Gastroenterol Clin Biol; 2000 Mar; 24(3):337-41. PubMed ID: 10804343
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of hepatitis C antibody screening in blood donors on post-transfusion hepatitis in Taiwan.
    Wang JT; Wang TH; Lin JT; Lee CZ; Sheu JC; Chen DS
    J Gastroenterol Hepatol; 1995; 10(4):454-8. PubMed ID: 8527713
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatitis C virus transfusion-transmitted infection in Brazilian cardiac surgery patients.
    Nogueira CA; Edelman DC; Nogueira CM; Nogueira SA; Coelho HS; Abrahão LJ; Vanderboght B; Lambert JS; Constantine NT
    Clin Lab; 2002; 48(9-10):529-33. PubMed ID: 12389714
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Current status of anti-HCV screening and posttransfusion hepatitis].
    Kiyokawa H
    Rinsho Byori; 1992 Sep; 40(9):925-8. PubMed ID: 1279246
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Persistent hepatitis C viremia after acute self-limiting posttransfusion hepatitis C.
    Barrera JM; Bruguera M; Ercilla MG; Gil C; Celis R; Gil MP; del Valle Onorato M; Rodés J; Ordinas A
    Hepatology; 1995 Mar; 21(3):639-44. PubMed ID: 7533121
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [A prospective study on post-transfusion hepatitis C].
    Wang A; Sheng R
    Zhonghua Nei Ke Za Zhi; 1996 Oct; 35(10):659-62. PubMed ID: 9592324
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Experiences with the "verification" of anti-HCV ELISA positive blood donors].
    Dengler T; Fürst G
    Beitr Infusionsther Transfusionsmed; 1994; 32():117-9. PubMed ID: 9480066
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.